"It is not for pharmaceutical use, it is intravenous, in hospitals exclusively for people who are already sick with coronavirus in the middle and severe stages," RIA Novosti quoted him as saying.
Earlier it became known that a therapeutic drug based on antibodies is being developed in Russia for the treatment of patients with coronavirus.
The Izvestia newspaper wrote that doctors from Russia and China linked the intake of blood pressure medications with the milder course of COVID-19 in patients over 65 years old.